Cargando…

Patient-centred management of Parkinson's disease

Detalles Bibliográficos
Autores principales:	Grimes, David, Antonini, Angelo, Ferreira, Joaquim J, Sanchez-Ferro, Álvaro, Lynch, Timothy, Rascol, Oliver, Růžička, Evžen, Eggers, Carsten, Mestre, Tiago A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577701/ https://www.ncbi.nlm.nih.gov/pubmed/33098790 http://dx.doi.org/10.1016/S1474-4422(20)30359-8

Ejemplares similares

Moving towards Integrated and Personalized Care in Parkinson’s Disease: A Framework Proposal for Training Parkinson Nurses
por: van Munster, Marlena, et al.
Publicado: (2021)

Co-Designing Digital Technologies for Improving Clinical Care in People with Parkinson’s Disease: What Did We Learn?
por: Monje, Mariana H. G., et al.
Publicado: (2023)

Technology-Enabled Care: Integrating Multidisciplinary Care in Parkinson's Disease Through Digital Technology
por: Luis-Martínez, Raquel, et al.
Publicado: (2020)

Remote Evaluation of Parkinson's Disease Using a Conventional Webcam and Artificial Intelligence
por: Monje, Mariana H. G., et al.
Publicado: (2021)

Patient-centred management of Parkinson's disease – Authors' reply
por: Bloem, Bastiaan R, et al.
Publicado: (2020)

Challenges and Perspectives in the Management of Late-Stage Parkinson’s Disease
por: Fabbri, Margherita, et al.
Publicado: (2020)

Espresso Coffee for the Treatment of Somnolence in Parkinson’s Disease: Results of n-of-1 Trials
por: Ferreira, Joaquim J., et al.
Publicado: (2016)

The Parkinson’s Real-World Impact Assessment (PRISM) Study: A European Survey of the Burden of Parkinson’s Disease in Patients and their Carers
por: Tolosa, Eduardo, et al.
Publicado: (2021)

Effect of Opicapone on Levodopa Pharmacokinetics in Patients with Fluctuating Parkinson's Disease
por: Ferreira, Joaquim J., et al.
Publicado: (2022)

Personalized Care in Late-Stage Parkinson’s Disease: Challenges and Opportunities
por: Fabbri, Margherita, et al.
Publicado: (2022)

Opicapone as an Add-on to Levodopa in Patients with Parkinson’s Disease Without Motor Fluctuations: Rationale and Design of the Phase III, Double-Blind, Randomised, Placebo-Controlled EPSILON Trial
por: Ferreira, Joaquim J., et al.
Publicado: (2022)

The Category of Conventional Physiotherapy: The Case of Parkinson’s Disease Guidelines
por: Hoskovcová, Martina, et al.
Publicado: (2022)

Parkinson’s Disease Drug Development Since 1999: A Story of Repurposing and Relative Success
por: Boucherie, Deirdre M., et al.
Publicado: (2021)

The Role of Parkinson Nurses for Personalizing Care in Parkinson’s Disease: A Systematic Review and Meta-Analysis
por: van Munster, Marlena, et al.
Publicado: (2022)

The Role of Architecture and Design in the Management of Parkinson’s Disease: A Systematic Review
por: Ramos, Joana Beisl, et al.
Publicado: (2020)

Physiotherapy in Parkinson's Disease: Building ParkinsonNet in Czechia
por: Gal, Ota, et al.
Publicado: (2017)

The Added Benefit of Opicapone When Used Early in Parkinson's Disease Patients With Levodopa-Induced Motor Fluctuations: A Post-hoc Analysis of BIPARK-I and -II
por: Rocha, José-Francisco, et al.
Publicado: (2021)

The safety/tolerability of opicapone when used early in Parkinson's disease patients with levodopa-induced motor fluctuations: A post-hoc analysis of BIPARK-I and II
por: Rocha, José-Francisco, et al.
Publicado: (2022)

Weight Gain Is Associated with Medial Contact Site of Subthalamic Stimulation in Parkinson's Disease
por: Růžička, Filip, et al.
Publicado: (2012)

Separate neural representations of depression, anxiety and apathy in Parkinson’s disease
por: Dan, Rotem, et al.
Publicado: (2017)

Short-term effect of dopaminergic medication on speech in early-stage Parkinson’s disease
por: Tykalova, Tereza, et al.
Publicado: (2022)

Opicapone versus placebo in the treatment of Parkinson’s disease patients with end-of-dose motor fluctuation-associated pain: rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trial
por: Chaudhuri, K. Ray, et al.
Publicado: (2022)

Short- and Long-Term Effects of DBS on Gait in Parkinson's Disease
por: Brozova, Hana, et al.
Publicado: (2021)

Selecting deep brain stimulation or infusion therapies in advanced Parkinson’s disease: an evidence-based review
por: Volkmann, Jens, et al.
Publicado: (2013)

Distinct patterns of speech disorder in early-onset and late-onset de-novo Parkinson’s disease
por: Rusz, Jan, et al.
Publicado: (2021)

The Management of Orthostatic Hypotension in Parkinson’s Disease
por: Sánchez-Ferro, Álvaro, et al.
Publicado: (2013)

Gait festination in parkinsonism: introduction of two phenotypes
por: Nonnekes, Jorik, et al.
Publicado: (2018)

Automated video-based assessment of facial bradykinesia in de-novo Parkinson’s disease
por: Novotny, Michal, et al.
Publicado: (2022)

Guidelines for the management of hidradenitis suppurativa: recommendations supported by the Centre of Evidence of the French Society of Dermatology
por: Bertolotti, A., et al.
Publicado: (2021)

Hypernasality associated with basal ganglia dysfunction: evidence from Parkinson’s disease and Huntington’s disease
por: Novotný, Michal, et al.
Publicado: (2016)

The Instrumental Activities of Daily Living in Parkinson’s Disease Patients Treated by Subthalamic Deep Brain Stimulation
por: Bezdicek, Ondrej, et al.
Publicado: (2022)

Let’s build youth treatment centres rather than detention centres
por: Akosile, Wole, et al.
Publicado: (2023)

Guidelines for the management of chronic spontaneous urticaria: recommendations supported by the Centre of Evidence of the French Society of Dermatology
por: Hacard, F., et al.
Publicado: (2021)

Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease
por: Mueller, Karsten, et al.
Publicado: (2018)

Basal Ganglia Neuronal Activity during Scanning Eye Movements in Parkinson’s Disease
por: Sieger, Tomáš, et al.
Publicado: (2013)

Topography of emotional valence and arousal within the motor part of the subthalamic nucleus in Parkinson’s disease
por: Serranová, Tereza, et al.
Publicado: (2019)

Abnormal Activity in the Precuneus during Time Perception in Parkinson's Disease: An fMRI Study
por: Dušek, Petr, et al.
Publicado: (2012)

Articulatory undershoot of vowels in isolated REM sleep behavior disorder and early Parkinson’s disease
por: Skrabal, Dominik, et al.
Publicado: (2022)

Regional gray matter changes and age predict individual treatment response in Parkinson's disease
por: Ballarini, Tommaso, et al.
Publicado: (2018)

Unraveling connectivity changes due to dopaminergic therapy in chronically treated Parkinson’s disease patients
por: Ballarini, Tommaso, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8l2icmo4nq93con4aqb1eits41